Dr. Robert Likic earned his medical degree with honours from the University of Zagreb Medical School in 2001, having previously received the Dean’s Award in 1999 for being the top medical student. Following his internship, he pursued specialist training in general internal medicine at the University Hospital Centre Zagreb, where he developed a strong interest in the effectiveness of problem-based learning in clinical pharmacology education. He became board-certified in internal medicine in 2007 and was awarded a PhD in 2008. Dr. Likic currently holds a tenured professorship in internal medicine and prescribing at the University of Zagreb Medical School. In parallel, he works as a consultant internist and clinical pharmacologist at the University Hospital Centre Zagreb. His research interests span medical education at both undergraduate and postgraduate levels, pharmacoeconomics, health technology assessment, medical informatics, and the rational use of medicines. He has been actively engaged in international collaborations, including organizing a multinational meeting on rational medicine use in Zagreb in 2008, funded by the British Council. In 2009, he was awarded the Matovinovic Fellowship, which enabled him to spend six months as a visiting scholar at the University of Michigan Medical School in Ann Arbor. To date, Dr. Likic has published over 100 research papers in journals indexed in Current Contents and has participated in numerous national and international conferences focused on pharmacology, clinical pharmacology, and pharmacoeconomics. He is a member of several national drug committees and scientific societies. Internationally, he serves on the board of the Education Committee of the European Association for Clinical Pharmacology and Therapeutics (EACPT), and he is also a councillor and treasurer of the Education Section of the International Union of Basic and Clinical Pharmacology (IUPHAR). Dr. Likic received the “Outstanding Early Educator Award” at the 16th IUPHAR World Congress of Basic and Clinical Pharmacology held in Copenhagen in 2010. In 2015, he served as executive advisor for therapeutics to the CEO of the University Hospital Centre Zagreb. Since 2017, he has been a member of the editorial board of the Croatian Medical Journal, and since 2020, he has served as a senior editor of the British Journal of Clinical Pharmacology.

Dr. Andrej Belančić is a (31 years old) Specialist in Clinical Pharmacology at the Department of Clinical Pharmacology, Clinical Hospital Centre Rijeka, Croatia. He also holds the academic title of Lecturer at the Department of Basic and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Rijeka, Croatia. In 2024, he was awarded the title of Best Young Scientist at the Faculty of Medicine, University of Rijeka. Dr. Belančić is the author or co-author of approximately 100 scientific and professional full-text articles and about 200 scientific abstracts. He has contributed as an author or co-author to several national guidelines in the field of metabolic diseases, authored multiple book chapters, and served as editor for several books, textbooks, and manuals. His scientific activities primarily focus on clinical pharmacology (treatment outcomes, pharmacoeconomics, pharmacovigilance, clinical trials), obesity and associated metabolic diseases, and rare disease therapeutics. He serves as Co-chair of the Early Career Clinical Pharmacologists Working Group of the European Association for Clinical Pharmacology and Therapeutics (EACPT) and is an active member of the Croatian Society for Clinical Pharmacology and Therapeutics of the Croatian Medical Association. He is also an active member of the European Society of Hypertension (ESH) Working Group on Diabetes and Metabolic Risk Factors, and the ESH Working Group on Lifestyle, Cardiovascular Therapy and Adherence. Dr. Belančić is a member of the Croatian Hypertension League, Secretary of the Croatian Society of Obesity of the Croatian Medical Association, and a member of the European Association for the Study of Obesity (EASO) and the World Obesity Federation (WOF). Furthermore, he is an active member of the Croatian Society for Diabetes and Metabolic Disorders of the Croatian Medical Association.